InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
5
T+90 hit rate
100%
T+90 mean return
+60.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pande Atul, Director. Officer active across 2 companies, notably Karuna Therapeutics, Inc.. Aggregated, 28 filings have been logged. Breakdown: 2 buys · 5 sells. Total volume traded: €584k. Activity tracked since 1 April 2021. The latest transaction was filed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Pande Atul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
1,500 shares@ US$8.43Common StockSEC:0001764013-26-000103:0
1,500 shares@ US$43.27Common StockSEC:0001764013-26-000103:1
1,500 shares@ US$39.800.0007% mcap9.7% of flowCommon StockSEC:0001643071-26-000007:1
1,500 shares@ US$8.430.0002% mcap2.1% of flowCommon StockSEC:0001643071-26-000007:0
1,500 sharesCommon StockSEC:0001764013-26-000071:0
1,500 sharesCommon StockSEC:0001764013-26-000071:1
13,880 shares0Common StockSEC:0001764013-26-000046:0
16,188 shares0Common StockSEC:0001764013-25-000047:0
7,750 shares@ US$28.5441.1% of flowCommon StockSEC:0001764013-24-000200:0
11,255 shares0Common StockSEC:0001764013-24-000061:0
990 shares@ US$330.0030.4% of flowCommon StockSEC:0001140361-24-013932:0
4,129 shares@ US$38.8028.8% of flowCommon StockSEC:0001764013-23-000155:0
990 shares0Common StockSEC:0000950170-23-029403:0
12,523 shares0Common StockSEC:0001764013-23-000047:0
15,000 shares@ US$5.6016.7% of flowCommon StockSEC:0001764013-22-000126:0
Canonical exit: 29 Dec 2022 (T+90)
21,059 shares0Common StockSEC:0001764013-22-000095:0
2,500 shares@ US$16.005.5% of flowCommon StockSEC:0001593968-22-000362:0
21,726 shares0Common StockSEC:0001764013-22-000015:0
2,500 shares@ US$16.005.5% of flowCommon StockSEC:0001593968-22-000017:0
2,500 shares@ US$16.005.5% of flowCommon StockSEC:0001593968-21-002517:0
2,500 shares@ US$16.005.4% of flowCommon StockSEC:0001593968-21-002355:0
2,500 shares@ US$16.005.4% of flowCommon StockSEC:0001593968-21-002217:0
2,500 shares@ US$16.005.3% of flowCommon StockSEC:0001593968-21-002050:0
5,000 shares@ US$7.986.3% of flowCommon StockSEC:0001764013-21-000088:0
Canonical exit: 11 Nov 2021 (T+90)
2,500 shares@ US$16.005.2% of flowCommon StockSEC:0001593968-21-001919:0
25 of 28 declarations
About Pande Atul
Pande Atul is Administrateur of Immunovant, Inc. and Karuna Therapeutics, Inc. He has 24 filings in total. Among the recent filings we hold, they cover the period from 2021-05-03 to 2026-06-26, with buys of EUR 119454 and sells of EUR 657041, and the most common transaction nature is Levée d'options.
